Citation Impact
Citing Papers
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management
2019
Cellular dissection of psoriasis for transcriptome analyses and the post-GWAS era
2014
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Cutaneous Immune Cell-Microbiota Interactions Are Controlled by Epidermal JunB/AP-1
2019
Optical coherence tomography angiography
2017 Standout
Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial
2010
Leishmaniasis
2018 Standout
10 Years Experience of the Dermatology Life Quality Index (DLQI)
2004 Standout
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
2018
American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
2014
An Acquired and Endogenous Glycocalyx Forms a Bidirectional “Don’t Eat” and “Don’t Eat Me” Barrier to Phagocytosis
2020 StandoutNobel
Psoriasis
2009 Standout
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
2008 Standout
Biologic Drugs for the Treatment of Hidradenitis Suppurativa: An Evidence-Based Review
2010
Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study
2008
Adherence to medication in patients with psoriasis: a systematic literature review
2012
Incidence of Hidradenitis Suppurativa and Associated Factors: A Population-Based Study of Olmsted County, Minnesota
2012 Standout
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Hidradenitis suppurativa: A comprehensive review
2009 Standout
Multicenter Study on Hepatitis C Virus–Related Cryoglobulinemic Glomerulonephritis
2007
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Efficacy of systemic therapies for moderate‐to‐severe psoriasis: a systematic review and meta‐analysis of long‐term treatment
2012
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
2015
C-type lectins in immunity and homeostasis
2018
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
2002 StandoutNature
Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata
2008
ORBIT (Outcome and Retention Rate of Biologic Treatments for Psoriasis): A retrospective observational study on biologic drug survival in daily practice
2016
Traditional systemic treatments have not fully met the needs of psoriasis patients: Results from a national survey
2005
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Therapy of psoriasis in childhood and adolescence ‐ a German expert consensus
2011
The changing landscape of atherosclerosis
2021 StandoutNature
Psoriasis
2021 Standout
American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
2014
In Vitro Induction of Human Regulatory T Cells Using Conditions of Low Tryptophan Plus Kynurenines
2017
Interaction between microbiota and immunity in health and disease
2020 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
microRNAs in Psoriasis
2016
Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics
2013
Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase
2008
Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
2017
Parvovirus B19 infection and autoimmune disease
2003
The immunogenetics of Psoriasis: A comprehensive review
2015
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
COSMIN guideline for systematic reviews of patient-reported outcome measures
2018 Standout
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
2012 Standout
Psoriasis
2015 Standout
PKDL and Other Dermal Lesions in HIV Co-infected Patients with Leishmaniasis: Review of Clinical Presentation in Relation to Immune Responses
2014
Obesity in autoimmune diseases: Not a passive bystander
2014
Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis
2009
An updated review of mechanotransduction in skin disorders: transcriptional regulators, ion channels, and microRNAs
2015
Chronic inflammatory diseases: Do immunological patterns drive the choice of biotechnology drugs? A critical review
2014
Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis
2014
Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action
2008
Prepubertal Hidradenitis Suppurativa Successfully Treated with Botulinum Toxin A
2009
TNFα blockade in human diseases: An overview of efficacy and safety
2007
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Disseminated Strongyloides stercoralis: Hyperinfection during medical immunosuppression
2010
Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression
2010
Regulation of tumour necrosis factor signalling: live or let die
2015
Treatment of Hidradenitis Suppurativa with Tumour Necrosis Factor-alpha Inhibitors
2009
Review: HIV infection and tropical parasitic diseases – deleterious interactions in both directions?
2002
Hidradenitis suppurativa
2020 Standout
Anti–tumor necrosis factor-α therapy in uveitis
2015
Patient-relevant treatment goals in psoriasis
2015
Prevention of Hepatitis B reactivation in the setting of immunosuppression
2016
Tumour necrosis factor-α inhibitor therapy in chronic physical illness: A systematic review and meta-analysis of the effect on depression and anxiety
2015
Efficacy of Infliximab for Hidradenitis Suppurativa: Assessment of Clinical and Biological Inflammatory Markers
2011
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
The interplay between cytokines and the Kynurenine pathway in inflammation and atherosclerosis
2017
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)
2015
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
2014 Standout
Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and Malaria
2006 Standout
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
2018
Recommendations for detection of individual risk for comorbidities in patients with psoriasis
2013
Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders
2016
Guidelines of care for the management of psoriasis and psoriatic arthritis
2009
Parvovirus B19
2004 Standout
Methotrexate versus Cyclosporine in Moderate-to-Severe Chronic Plaque Psoriasis
2003
Leishmaniasis
1999 Standout
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities
2011 Standout
Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review
2016
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Papular-purpuric "gloves and socks" syndrome due to parvovirus B19: report of a case with unusual features
2001
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
2015 Standout
Management of psoriasis in adolescence
2014
Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled TRANSFIGURE trial
2018
Long-term efficacy of infliximab in hidradenitis suppurativa
2012
Leishmania and human immunodeficiency virus coinfection: the first 10 years
1997
Psoriasis Pathogenesis and Treatment
2019 Standout
Human Parvovirus B19
2002 Standout
Gloves and socks syndrome: Early and late histopathologic features
2002
Nail Psoriasis: A Review of Treatment Options
2016
Emerging biomarkers in psoriatic arthritis
2015
Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials
2017
Motivational interviewing-based training enhances clinicians’ skills and knowledge in psoriasis: findings from the Pso Well®study
2016
Antifolate Activity of Epigallocatechin Gallate against Stenotrophomonas maltophilia
2005 Standout
Wound Healing: A Cellular Perspective
2018 Standout
Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa
2012 Standout
The Illusion of Sustainability
2007 StandoutNobel
Laser capture microdissection followed by next‐generation sequencing identifies disease‐related microRNA s in psoriatic skin that reflect systemic microRNA changes in psoriasis
2014
Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect?
2013
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Drug Resistance in Leishmaniasis
2006 Standout
Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases
2008
The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials
2016
Works of E. Daudén being referenced
Patient-relevant needs and treatment goals in nail psoriasis
2015
Juvenile psoriasis and its clinical management: a European expert group consensus
2010
Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: A 2-year cohort study
2001
Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus
2006
CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis
2016
Consensus document on the evaluation and treatment of moderate‐to‐severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology
2016
Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study
2009
Treatment and Management of Psoriasis with Nail Involvement: A Focus on Biologic Therapy
2010
Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis
2012
Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases
2013
Leishmaniasis presenting as a dermatomyositis-like eruption in AIDS
1996
Diseño y validación de un cuestionario para medir la satisfacción con el tratamiento del paciente con psoriasis moderada y grave: estudio NEODERMA
2010
CRYOGLOBULINEMIA AND CUTANEOUS LEUKOCYTOCLASTIC VASCULITIS WITH HEPATITIS C VIRUS INFECTION
1996
The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics
2009
Abordaje integral de la comorbilidad del paciente con psoriasis
2012
Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting
2012
Riesgo de reactivación de hepatitis B pasada en pacientes con psoriasis tratados con biológicos. Análisis retrospectivo de 20 casos. Registro de BIOBADADERM
2015
PAPULAR‐PURPURIC GLOVES‐AND‐SOCKS SYNDROME
1996
Lupus erythematosus‐like lesions in a carrier of X‐linked chronic granulomatous disease
2000
Hidrosadenitis supurativa. Respuesta al tratamiento con infliximab
2007
Position statement for the management of comorbidities in psoriasis
2018
Efficacy and safety of continuous versus paused etanercept treatment in patients with moderate-to-severe psoriasis over 54 weeks: the CRYSTEL study
2008
Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers
2006
Body mass index in patients with moderate‐to‐severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry
2013
Practical Management of Hidradenitis Suppurativa
2008
Outcome of patients with serology suggestive of past hepatitis B virus infection during antitumor necrosis factor therapy for psoriasis
2014
Validation of the Spanish Version of the Itch Severity Scale: The PSEDA Study
2011
The relationship between tumour necrosis factor (TNF)-α promoter andIL12B/IL-23Rgenes polymorphisms and the efficacy of anti-TNF-α therapy in psoriasis: a case-control study
2013
Spanish Evidence-Based Guidelines on the Treatment of Moderate to Severe Psoriasis with Biologic Agents
2009
Recommendations for the management of comorbidity in hidradenitis suppurativa
2017
Genetics of Psoriasis and Pharmacogenetics of Biological Drugs
2013
Hidradenitis Suppurativa. Response to Treatment With Infliximab
2007
KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential
2022
Risk of Reactivation of Hepatitis B Virus Infection in Psoriasis Patients Treated With Biologics: A Retrospective Analysis of 20 Cases From the BIOBADADERM Database
2015
Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis moderada a grave con agentes biológicos
2009
Integrated Approach to Comorbidity in Patients With Psoriasis
2012
Juvenile Psoriasis und ihre Behandlungsmöglichkeiten: Konsensus einer europäischen Expertengruppe
2010
Targeting miR-21 to Treat Psoriasis
2014
The Polymorphism Rs763780 in the IL-17F Gene is Associated with Response to Biological Drugs in Patients with Psoriasis
2015
Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis
2016
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes
2013
Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort
2015
Manejo práctico de la hidrosadenitis supurativa
2008